Journal of Neurotrauma, 2023 · DOI: 10.1089/neu.2022.0177 · Published: May 1, 2023
This study investigates the role of PERK, a protein involved in cellular stress response, after spinal cord injury (SCI) in mice. The researchers found that inhibiting PERK shortly after SCI improved the recovery of movement and reduced damage to white matter in the spinal cord. The study suggests that excessive activation of PERK after SCI contributes to white matter damage. The scientists observed increased numbers of oligodendrocytes, cells critical for nerve insulation, in mice treated with a PERK inhibitor called GSK2656157. In laboratory experiments, GSK2656157 protected oligodendrocyte precursor cells from stress-induced damage. This suggests that targeting PERK could be a potential therapeutic strategy to protect the central nervous system after acute injuries like SCI.
Pharmacological inhibition of PERK represents a potential therapeutic target in CNS trauma.
Oral administration of GSK2656157 may allow contused mice to recover from some coordination to mostly coordinated weight bearing and plantar stepping.
Identify novel therapeutics that can effectively modulate PERK signaling without major toxic side effects.